Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - TAX PROVISION
Tax Provision URGN - UroGen Pharma Ltd.
3.92 M
LAST VALUE
64.48%
2 YEAR CAGR
99.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR